In this special episode of DTx Podcast, Eugene is joined by Brent Vaughan, CEO of Cognito, as well as industry leaders from previous episodes, to weigh in on the recent Pear Therapeutics news and the future of prescription digital therapeutics.
In this episode, we cover:
The impact on the PDT marketFuture efforts to move DME to PDTThe impact on the entrepreneurs currently developing PDT’sPredictions on the future of Pear TherapeuticsReflections on the history and future of DTx from Chris Bergstrom (Amalgam RX), David Klein (Click Therapeutics), Andy Molnar (DTA), Sammeli Liikkanen (Orion), Francesca Wuttke (nen), Andrzej Jonczyk (Prosoma), Steve Driver (Advocate Health) and Grady Hannah (NightWare)
Join the HealthXL platform for free today and be the first to read their analysis of Pear’s predicament and what it means for the DTx industry: https://portal-beta.healthxl.com/?s=2fb5
Guest Links and Resources:
Connect with Brent Vaughan on LinkedInConnect with Chris Bergstrom on LinkedInConnect with David Klein on LinkedInConnect with Andy Molnar on LinkedInConnect with Sammeli Liikkanen on LinkedInConnect with Francesca Wuttke on LinkedInConnect with Andrzej Jonczyk on LinkedInConnect with Steve Driver on LinkedInConnect with Grady Hannah on LinkedInConnect with Eugene Borukhovich: Twitter | LinkedInConnect with Chandana Fitzgerald, MD: Twitter | LinkedInConnect with YourCoach.health: Website | TwitterCheck out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast AppHealthXL: Website | Twitter | Join an Event
Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health | Orion Pharma
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram